Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Overweight 1Obesity 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Lidocaine 2Injections 2Docosahexaenoic Acids 2Diet 2sibutramine 1polyethylene glycol 3350 1oxycodone-acetaminophen 1naloxegol 1naldemedine 1methylnaltrexone 1Ursodeoxycholic Acid 1Tramadol 1Topiramate 1Solutions 1Sennosides 1Resistance Training 1Quality of Life 1Propofol 1Progestins 1Polyethylene Glycols 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cyproterone × Other × Clear all
NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed
70 enrolled 11 charts
Other

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡